WASHINGTON -- (BUSINESS WIRE) -- The Biotechnology Industry Organization (BIO) today announced the initial selection of presenting companies for the 15th Annual BIO CEO & Investor Conference to be held February 11-12, 2013 in New York City. All presenting companies are hand-selected for the event, and consist of both private companies and mid-to-large cap established public companies from around the globe. Companies are chosen based on a selection process evaluating a company’s pipeline and R&D activities as well as their focus on biotechnology therapeutics.
“This year’s conference will better accommodate the growing diversity of investors and companies. While the majority of presenting companies at our event are publicly traded, with about half trading with market capitalizations above $100M, for the first time this meeting will also include a unique track that features up to 25 high-caliber and established private company presentations,” said Alan Eisenberg, Executive Vice President of Emerging Companies and Business Development at BIO.
The following companies are slated to present at this year’s conference:
Check back often as new presenters are continuously being added. Companies interested in presenting their story can submit an application at http://www.bio.org/events/conferences/bio-ceo-application-present.
About BIO CEO & Investor Conference
The BIO CEO & Investor Conference is the largest investor conference focused on publicly traded biotech companies. Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. The BIO CEO & Investor Conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities. BIO is pleased to recognize the leadership provided by the BIO CEO & Investor Conference sponsors including supporting banks Stifel Nicolaus Weisel, Leerink Swann and ROTH Capital Partners, LLC.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.
Upcoming BIO Events
Asia International Conference
January 29 - 30, 2013
CEO & Investor Conference
February 11 - 12, 2013
New York City, NY
March 25 - 27, 2013
San Diego, CA
April 22 - 25, 2013
Congress on Industrial Biotechnology
June 16 - 19, 2013